FULL PAPERS
Potassium Phosphate-Catalyzed Chemoselective Reduction of a-Keto Amides
133.0, 128.2, 128.1, 127.9, 127.7, 126.7, 126.1, 126.0, 125.6,
122.2, 121.7, 74.0; IR (KBr): n=3409, 3005, 1659, 1541,
1499, 1436, 1092 cmÀ1; HR-MS: m/z=300.0990 [M+Na]+,
calcd. for C18H15N1O2Na1: 300.1000.
2-Hydroxy-N-{4-[(2-oxo-2-phenylacetamido)methyl]phen-
yl}-2-phenylacetamide (2n): Colourless solid; mp 176–
1778C; Rf =0.38 (hexanes:ethyl acetate, 70:30 v/v); H NMR
1
(400 MHz, DMSO-d6): d=9.91 (s, 1H), 9.38 (t, J=6.0 Hz,
1H), 7.95–7.99 (m, 2H), 7.64–7.75 (m, 3H), 7.54–7.61 (m,
2H), 7.49–7.53 (m, 2H), 7.32–7.38 (m, 2H), 7.24–7.31 (m,
3H), 6.42 (d, J=4.4 Hz, 1H), 5.10 (d, J=4.4 Hz, 1H), 4.40
(d, J=6.0 Hz, 2H); 13C NMR (100 MHz, DMSO-d6): d=
190.3, 171.1, 164.9, 140.8, 137.5, 134.6, 133.6, 132.9, 129.7,
129.0, 128.1, 127.8, 127.6, 126.6, 119.8, 74.0, 41.5; IR (KBr):
n=3567, 3537, 3058, 1793, 1711, 1612, 1090, 1074 cmÀ1; HR-
MS: m/z=411.1313 [M+Na]+, calcd. for C23H20N2O4Na1:
411.1321.
2-Hydroxy-2-phenyl-N-[4-(trifluoromethyl)phenyl]aceta-
mide (2g): Colourless solid; mp 175–1768C; Rf =0.40 (hexa-
nes:ethyl acetate, 80:20 v/v); 1H NMR (400 MHz, DMSO-
d6): d=10.31 (bs,1H), 7.94 (d, J=8.4 Hz, 2H), 7.65 (d, J=
8.4 Hz, 2H), 7.52 (d, J=7.2 Hz, 2H), 7.26–7.41 (m, 3H),
6.53 (d, J=4.4 Hz, 1H), 5.14 (d, J=4.0 Hz, 1H); 13C NMR
(100 MHz, DMSO-d6): d=171.8, 142.1, 140.5, 134.4, 128.1,
127.9, 127.7, 126.6, 125.9 (q, J=4.0 Hz, CF3), 119.7, 74.1; IR
(KBr): n=3293, 1657, 1601, 1557, 1543, 1116 cmÀ1; HR-MS:
m/z=318.0705 [M+Na]+, calcd. for C15H12N1O2F3Na1:
318.0718.
2-Hydroxy-N-[4-(2-hydroxy-2-phenylacetamido)benzyl]-2-
phenylacetamide (2o): Colourless solid; mp 191–1928C; Rf =
1
2-Hydroxy-N-(3-nitrophenyl)-2-phenylacetamide
(2h):
0.32 (hexanes:ethyl acetate, 60:40 v/v); H NMR (400 MHz,
Colourless solid; mp 142–1438C; Rf =0.42 (hexanes:ethyl
acetate, 70:30 v/v); 1H NMR (400 MHz, DMSO-d6): d=
10.49 (bs,1H), 8.76 (s, 1H), 8.12 (d, J=7.6 Hz, 1H), 7.91
(dd, J=8.2, 1.4 Hz, 1H), 7.48–7.63 (m, 3H), 7.20–7.40 (m,
3H), 6.58 (d, J=4.4 Hz, 1H), 5.16 (d, J=4.0 Hz, 1H);
13C NMR (100 MHz, DMSO-d6): d=172.1, 147.9, 140.5,
139.8, 130.0, 128.2, 127.8, 126.6, 125.9, 118.1, 113.9, 74.1; IR
(KBr): n=3292, 1653, 1647, 1595, 1507, 1062 cmÀ1; HR-MS:
m/z=273.0887 [M+H]+, calcd. for C14H13N2O4: 273.0875.
DMSO-d6): d=9.86 (s, 1H), 8.46 (t, J=6.2 Hz, 1H), 7.58
(dd, J=7.0, 2.0 Hz, 2H), 7.53–7.47 (m, 2H), 7.39–7.44 (m,
2H), 7.23–7.38 (m, 6H), 7.11 (d, J=8.8 Hz, 2H), 6.41 (d, J=
4.8 Hz, 1H), 6.17 (d, J=4.8 Hz, 1H), 5.08 (d, J=4.8 Hz,
1H), 4.95 (d, J=4.8 Hz, 1H), 4.21 (dd, J=6.0, 2.8 Hz, 1H);
13C NMR (100 MHz, DMSO-d6): d=172.2, 171.0, 141.3,
140.9, 137.1, 134.7, 128.1, 127.9, 127.6, 127.4, 126.6, 126.5,
119.6, 74.0, 73.6, 41.3; IR (KBr): n=3552, 3546, 1706, 1700,
1653, 1647, 1636, 1363, 1228 cmÀ1; HR-MS: m/z=411.1470
[M+Na]+, calcd. for C23H22N2O4Na1: 413.1477.
N-(4-Chlorophenyl)-2-hydroxy-2-phenylacetamide
(2i):
Colourless solid; mp 97–988C; Rf =0.36 (hexanes:ethyl ace-
tate, 80:20 v/v); H NMR (400 MHz, DMSO-d6): d=9.64 (s,
2-Hydroxy-2-phenyl-N-(pyridin-2-yl)acetamide (2p): Col-
ourless solid; mp 119–1208C; Rf =0.38 (hexanes:ethyl ace-
tate, 80:20 v/v); H NMR (400 MHz, DMSO-d6): d=9.95 (s,
1
1
1H), 8.09 (dd, J=8.2, 1.4 Hz, 1H), 7.46–7.55 (m, 3H), 7.29–
7.40 (m, 4H), 7.12–7.19 (m, 1H), 6.93 (d, J=4.4 Hz, 1H),
5.18 (d, J=4.4 Hz, 1H); 13C NMR (100 MHz, DMSO-d6):
d=170.8, 140.4, 134.1, 129.3, 128.2, 127.83, 127.8, 126.7,
125.5, 123.8, 122.2, 73.6; IR (KBr): n=3235, 1666, 1614,
1604, 1556, 1072 cmÀ1.
1H), 8.30–8.35 (m, 1H), 8.03 (dt, J=8.4, 0.8 Hz, 1H), 7.75–
7.82 (m, 1H), 7.48–7.54 (m, 2H), 7.25–7.39 (m, 3H), 7.09–
7.16 (m, 1H), 6.52 (d, J=5.2 Hz, 1H), 5.23 (d, J=5.2 Hz,
1H); 13C NMR (100 MHz, DMSO-d6): d=171.4, 151.0,
148.1, 140.4, 138.4, 128.1, 127.7, 126.6, 119.9, 113.1, 73.3; IR
N-(4-Chlorophenyl)-2-hydroxy-2-phenylacetamide (2j):[27]
Colourless solid; mp 159–1608C (Lit.[27] mp 161–1648C);
Rf =0.54 (hexanes:ethyl acetate, 80:20 v/v); 1H NMR
(400 MHz, DMSO-d6): d=10.08 (s, 1H), 7.75 (dd, J=6.8,
2.0 Hz, 2H), 7.51 (d, J=7.2 Hz, 2H), 7.39–7.26 (m, 5H),
6.48 (d, J=4.8 Hz, 1H), 5.10 (d, J=4.8 Hz, 1H); 13C NMR
(100 MHz, DMSO-d6): d=171.4, 140.7, 137.5, 128.5, 128.1,
127.7, 127.1, 126.6, 121.3, 74.0; IR (KBr): n=3298, 1696,
1684, 1653, 1522, 1065 cmÀ1; HR-MS: m/z=284.0460 [M+
Na]+, calcd. for C14H12N1O2Cl1Na1: 284.0454.
(KBr): n=3358, 1671, 1577, 1517, 1507, 1436, 1304 cmÀ1
;
HR-MS:
m/z=251.0791
[M+Na]+,
calcd.
for
C13H12N2O2Na1: 251.0796.
2-Hydroxy-N-methyl-N,2-diphenylacetamide (2q):[14] Col-
ourless solid; mp 89–908C (Lit.[14] mp 89–908C); Rf =0.40
(hexanes:ethyl acetate, 80:20 v/v); 1H NMR (400 MHz,
CDCl3): d=7.08–7.35 (m, 6H), 6.70–6.90 (m, 4H), 5.00 (s,
1H), 3.30 (s, 1H); 13C NMR (100 MHz, CDCl3): d=173.0,
141.6, 139.4, 129.7, 128.5, 128.2, 128.1, 127.4, 71.8, 38.4; IR
(KBr): n=3422, 1648, 1605, 1594, 1496, 1369, 1085 cmÀ1.
N-(4-Cyanophenyl)-2-hydroxy-2-phenylacetamide (2k):[14]
Colourless solid; mp 131–1328C (Lit.[14] mp 130–1318C);
Rf =0.38 (hexanes:ethyl acetate, 80:20 v/v); 1H NMR
(400 MHz, DMSO-d6): d=10.36 (s, 1H), 7.93 (d, J=8.8 Hz,
2H), 7.75 (d, J=8.8 Hz, 2H), 7.51 (d, J=7.2 Hz, 2H), 7.26–
7.41 (m, 3H), 6.55 (d, J=4.4 Hz, 1H), 5.15 (d, J=4.4 Hz,
1H); 13C NMR (100 MHz, DMSO-d6): d=172.1, 142.8,
140.4, 133.1, 128.2, 127.8, 126.6, 119.8, 118.99, 105.3, 74.1; IR
(KBr): n=3670, 1946, 1675, 1653, 1603, 1559 cmÀ1.
4-(2-Hydroxy-2-phenylacetamido)benzamide (2l): Colour-
less solid; mp 161–1628C; Rf =0.32 (hexanes:ethyl acetate,
70:30 v/v); 1H NMR (400 MHz, DMSO-d6): d=10.12 (s,
1H), 7.70–7.95 (m, 5H), 7.52 (d, J=6.8 Hz, 2H), 7.16–7.44
(m, 4H), 6.48 (s, 1H), 5.13 (s, 1H); 13C NMR (100 MHz,
DMSO-d6): d=171.5, 167.3, 141.1, 140.6, 129.1, 128.2, 128.1,
127.7, 126.6, 118.8, 70.0; IR (KBr: n=3361, 1653, 1623,
1596, 1522 cmÀ1.
N-Ethyl-2-hydroxy-N,2-diphenylacetamide
(2r):
Oily
1
liquid; Rf =0.44 (hexanes:ethyl acetate, 80:20 v/v); H NMR
(400 MHz, CDCl3): d=7.10–7.34 (m, 6H), 6.69–6.85 (m,
4H), 4.92 (s, 1H), 3.87–4.00 (m, 1H), 3.52–3.64 (m, 1H) 3.35
(bs, 1H), 1.12 (t, J=7.2 Hz, 3H); 13C NMR (100 MHz,
CDCl3): d=172.4, 139.9, 139.6, 129.5, 129.2, 128.5, 128.4,
128.1, 127.5, 71.9, 45.5, 12.9; IR (neat): n=3421, 3063, 1652,
1595, 1454, 1380, 1092 cmÀ1.
2-Hydroxy-N-(4-methoxybenzyl)-2-phenylacetamide (2s):
Colourless solid; mp 141–1428C; Rf 0.36 (hexanes:ethyl ace-
1
tate, 80:20 v/v); H NMR (400 MHz, CDCl3): d=7.32–7.45
(m, 5H), 7.11 (d, J=7.6 Hz, 2H), 6.83 (d, J=7.6 Hz, 2H),
6.43 (bs, 1H), 5.06 (s, 1H), 4.37 (d, J=6.8 Hz, 2H), 3.78 (s,
3H), 2.38 (bs, 1H); 13C NMR (100 MHz, CDCl3): d=172.1,
159.2, 139.5, 129.9, 129.2, 129.1, 128.9, 127.0, 114.2, 74.4,
55.4, 43.3; IR (KBr): n=3220, 2965, 1712, 1635, 1540, 1459,
1065 cmÀ1.
Adv. Synth. Catal. 2016, 358, 643 – 652
ꢀ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
649